(S)-(2-((1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)oxy)-4-(3,5-dimethylisoxazol-4-yl)phenyl)boronic acid

Catalog No. :
ACYNFU331
CAS No. :
1609116-59-7
Molecular Formula :
C20H27BN2O6
Molecular Weight :
402.26

IUPAC Name:(S)-(2-((1-(tert-butoxycarbonyl)pyrrolidin-3-yl)oxy)-4-(3,5-dimethylisoxazol-4-yl)phenyl)boronic acid

(S)-(2-((1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)oxy)-4-(3,5-dimethylisoxazol-4-yl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$521.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-(2-((1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)oxy)-4-(3,5-dimethylisoxazol-4-yl)phenyl)boronic acid
IUPAC Name(S)-(2-((1-(tert-butoxycarbonyl)pyrrolidin-3-yl)oxy)-4-(3,5-dimethylisoxazol-4-yl)phenyl)boronic acid
Molecular FormulaC20H27BN2O6
Molecular Weight402.26
SMILESCC1=C(C2=CC=C(B(O)O)C(O[C@@H]3CN(C(OC(C)(C)C)=O)CC3)=C2)C(C)=NO1
InChI KeySGPRMFJLMDVECR-HNNXBMFYSA-N
Synonym1-Pyrrolidinecarboxylic acid, 3-[2-borono-5-(3,5-dimethyl-4-isoxazolyl)phenoxy]-, 1-(1,1-dimethylethyl) ester, (3S)-;(S)-(2-((1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)oxy)-4-(3,5-dimethylisoxazol-4-yl)phenyl)boronic acid
CAS No.1609116-59-7

Synthetic Route by SureRoute

1. ACYNFU331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYZIQ054 route compound structure diagram
    ACYZIQ054832114-00-8 In Stock
  4. Then
  5. ACYNFU331 route product structure diagram
    ACYNFU3311609116-59-7
Inquiry

2. ACYNFU331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACROGU189 route compound structure diagram
    ACROGU18916114-47-9 In Stock
  4. Then
  5. ACYNFU331 route product structure diagram
    ACYNFU3311609116-59-7
Inquiry

Comments (0)